FDA warns on antipsychotic use in pregnancy; NICE blesses GSK cancer med Votrient;

@FiercePharma: M&A fills patent holes, fuels geographic expansion. Report | Follow @FiercePharma

> The anti-addiction drug Antabuse will be tested in HIV-infected patients as a potential weapon against the reservoirs of virus that remain even after treatment with AIDS drugs. Story

> The FDA issued a safety alert about the risks to newborns of exposure to nearly two dozen antipsychotics during pregnancy. Article

> NICE has recommended GlaxoSmithKline's kidney cancer drug Votrient on the same day it gave a final negative decision to Roche's Avastin in breast cancer. Report

> Eisai said the Japan Intellectual Property High Court ruled in favor of extending its patent for the Alzheimer's drug Aricept until June 2013. News

> Detroit's Caraco Pharmaceutical has agreed to merge with India-based majority owner Sun Pharmaceutical Industries. Item

> The federal government is questioning whether our neighbors to the north will be looking out for the U.S. taxpayers in a Canadian pharmaceutical company's insolvency case. News

Biotech News

@FierceBiotech: FDA chief vows fast delivery of new biosimilar rules. Report | Follow @FierceBiotech

@JohnCFierce: So, how about it scribes? Is Vertex the smartest drug developer out there? | Follow @JohnCFierce 

> Gilead's Calistoga buyout marks effort to make cancer a chronic condition. Article

> PPD steps in as Elan's go-to CRO for development work. Item

> Vertex dazzles analysts with landmark Ph3 CF results. News

Drug Delivery News

> FluGen lands $7.8M for microneedle vaccine delivery patch. News

> MIT tests new nanoparticle for vaccine delivery. Report

> MannKind job cuts hit CT site after FDA rejects inhaled insulin. Report

> Boston Scientific charts stent growth in India. Story

> Versartis grabs $21M Series B, aims to begin study of once-monthly hormone therapy. Article

Medical Device News

> Devicemakers explore pacemakers for psychiatric disease. Story

> FDA device approval: Too fast or too slow? Report

> Amendia expands as it raises cash. Article

> gets FDA OK for dialysis machine. News

> J&J recalls 400 arthritis treatment pens. Report

And Finally... A study shows that bisphosphonate drugs do reduce the risk of typical fractures caused by osteoporosis, but may also increase the risk of other, "atypical" fractures. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.